Sponsors

Pangaea Data named ‘Digital Solution of the Year' by Department for International Trade

Pangaea Data, which provides a novel AI-driven product for characterising patients by mapping their journeys and disease trajectories in a privacy-preserving and scalable manner, has announced that it has been named ‘Digital Solution of the Year’ by the UK Government’s Department for International Trade (DIT), as part of its 2023 UK Life Science Innovator Showcase.

UK DIT selected Pangaea for this award from thousands of UK companies across the life science industry as a direct result of its international growth and innovative approach to tackling healthcare challenges.

This award follows Pangaea’s selection by the UK DIT as a Leading Digital Health Innovator, and inclusion in the UK government’s Digital Health Playbook for the second consecutive year. The UK Digital Health Playbook showcases the top UK innovators and exporters, providing solutions for current challenges in digital health, including scaling the power of AI for improved diagnoses and more accurate predictions.

Pangaea’s AI-driven product, Pangaea’s Intelligence Extraction and Summarization (PIES), characterises patients by mapping their journeys and disease trajectories in an evolving, federated privacy-preserving and scalable manner, which is critical for preventative health and precision medicine. This is achieved by PIES unlocking and summarising clinically actionable intelligence from patient records, which has proven to find 22 times more undiagnosed, miscoded and at-risk patients; match patients to five times more suitable clinical trials and therapies; discover new relationships between drugs, features and adverse events; predict prognosis; halve treatment costs; and save 90% in costs and time compared to manual and alternative natural language processing (NLP)- based methods.

Dr Vibhor Gupta, CEO and Founder of Pangaea, said: “We are proud to have been selected by DIT for this award, which highlights the value we have created for both patients and clinicians through our novel AI-driven product, which will be critical in realising the promise of preventative health and precision medicine across the healthcare and pharmaceutical industry. This is also a testament to our proven track-record of success and collaboration, as well as our continued commitment to international expansion.”

Learn more about Pangaea by visiting www.pangaeadata.ai.

 

Latest Issues

BSMT 40th Anniversary Microbiology Conference

RAF Museum, Hendon, London NW9 5LL
15 May, 2025

Transforming Digital Pathology & AI: The Path Forward

Royal College Of Physicians Of Edinburgh
15 May, 2025

The 10 Year Plan - Clinical Innovations Expo

Jubilee Hotel and Conference Centre, Nottingham, UK
15 May, 2025